Fourteen specialty strengths. One gateway to Guangzhou.

Guangzhou hosts the medical platform behind the WHO's only collaborating centre for cardiovascular research and training in the Western Pacific. Its centres lead internationally in complex congenital heart disease, arrhythmia and coronary artery disease, routinely performing TAVI, ECMO and in-utero fetal intervention. Annual cardiac surgery exceeds 7,000 cases, heart-transplant volume set a national single-centre record, and 24/7 international transfer and critical care are available. The international wing introduced the Hong Kong private-hospital operating model in 1996 — a national first — and has served patients from 151 countries and regions.

Nasopharyngeal cancer & precision radiotherapy. A national cancer platform in Guangzhou treats 7,000+ nasopharyngeal cancer cases a year, ranked first globally in academic output. Its "more effective, less toxic" treatment system has rewritten international guidelines — over 95% precision radiotherapy, 71+ results adopted into international standards. Its international medical centre opened in July 2026, with academicians and nationally renowned physicians on rotation, five service packages from premium screening to full-course management, and a paediatric-oncology teleconsultation channel with a top European cancer institute and a Barcelona children's hospital (consultation fees reduced by 60%).

Liver-cancer radionuclide therapy. A hospital with an overseas-Chinese heritage performs the world's highest volume of Y-90 microsphere surgery for large liver tumours; its CAR-T cell therapy for blood cancers leads South China, with over half of those patients arriving from overseas, Hong Kong, Macao and Taiwan.

Integrative "green" oncology. A private international hospital combines hyperthermia, ozone and natural therapies with CyberKnife and PET-CT, having served patients from 180+ countries and regions.

Lung & pancreatic cancer. A general hospital's lung-cancer institute is led by an IASLC Distinguished Science Award winner, integrating nodule screening, precision resection and individualised therapy; its pancreatic centre — the national pancreatic-cancer committee chair unit — achieves a minimally invasive rate above 95%.

Guangzhou hosts China's National Center for Respiratory Medicine, the country's only state key laboratory for respiratory disease, and an academician-led team. Its internationally pioneered "tubeless" thoracic surgery has entered the Harvard Medical School curriculum. On Datansha Island, an international respiratory medical centre with over ¥1.6 billion investment and 1,000 new beds is under construction — a destination for complex respiratory care serving patients worldwide, especially from Southeast Asia.

Ischaemia-free transplantation. A Guangzhou hospital invented ischaemia-free organ transplantation — liver, kidney and beating-heart world firsts — adopted into international transplant guidelines in 2023. Its new international medical centre brings together 36 national key clinical specialties with international MDT and telemedicine, a rooftop rescue helipad anchoring a 30-minute Greater Bay Area emergency circle, and the world-first "mobile ICU" — admission begins the moment the patient boards.

Liver transplantation & severe liver disease. Another hospital leads nationally in severe hepatitis rescue and living-donor liver transplantation.

Haematopoietic stem-cell transplantation. A century-old hospital's Nansha campus operates one of South China's largest laminar-flow ward complexes and the province's largest radionuclide therapy ward.

Guangzhou is home to China's only WHO collaborating centre for eye health and vision — the country's largest public eye hospital. Its international medical service launched in April 2026 with 4,000+ m² of dedicated zones in Zhujiang New Town and Guangzhou International Bio Island, covering all 14 ophthalmic sub-specialties, an internationally recognised centre for complex and rare eye diseases. Self-developed highlights include a 10-micron ophthalmic surgical robot, the ChatZOC eye-care AI model and 5G smart eye-screening vehicles. Foreign outpatient visits reached 4,175 in 2025 — about a quarter from the United States — growing 15.9% a year on average over three years, with complex cases exceeding half. International cards (VISA and others) and direct billing with 10+ commercial insurers are supported.

South China's top-ranked stomatology platform — a national regional dental medical centre — has opened a dedicated International Dental Medical Centre in its new Tianhe campus: full English-language reception and multilingual service across all 8 national key clinical specialties, from head-and-neck tumour resection and reconstruction to microscopic endodontics, dynamic-navigation digital implantology and invisible orthodontics. Many of its dentists trained at Harvard, the University of Hong Kong and other overseas institutions.

The breast tumour centre of China's first western-medicine hospital is academician-led, with a 92.6% five-year survival rate for early breast cancer at world-leading level. A comprehensive hospital's breast surgery offers genomics-guided precision individualised treatment and robot-assisted breast-conserving surgery in step with international practice.

One hospital's joint-surgery team replaces joints with sub-millimetre robotic precision — a "function first, early rehab, return to sport" philosophy that has returned national-level athletes to competition. An overseas-Chinese-heritage hospital has performed nearly 8,000 laparoscopic bariatric procedures and leads nationally in robotic joint replacement, and partnered with Macao to complete Macao's first domestically made fully magnetically levitated artificial-heart implant.